Lorazepam recalls

Lorazepam products have been recalled 7 times, most recently on 6 Aug 2025. The recalling company is usually Hikma Pharmaceuticals USA. The most common reason is potency & assay.

Total recalls7since 2017

Last 12 months0reported

Class I114% of total

Ongoing1latest 6 Aug 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 1 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 1 14%Class II 6 86%Class III 0 0%

Why lorazepam is recalled

Potency & Assay571%
Other Reasons229%

Companies

Product types

Anxiety & Sleep Medication7100%

By year

2025114%
2023114%
2022343%
2017229%

Ongoing lorazepam recalls

1 active

Reported	Class	Recall	Company	Reason	Where
6 Aug 2025Drug	CLASS II	Lorazepam Injection, USP, 2 mg/mL, 25 x vials/carton recalledLorazepam	Hikma Pharmaceuticals USA	Potency & Assay	Nationwide

All lorazepam recalls, newest first

7 total

Reported	Class	Recall	Company	Reason	Where
6 Aug 2025Drug	CLASS II	Lorazepam Injection, USP, 2 mg/mL, 25 x vials/carton recalledLorazepam	Hikma Pharmaceuticals USA	Potency & Assay	Nationwide
24 May 2023Drug	CLASS II	Lorazepam Injection, USP, 2mg/mL vial recalledLorazepam	Hikma Pharmaceuticals USA	Potency & Assay	Nationwide
17 Aug 2022Drug	CLASS II	Lorazepam Injection, USP, 2mg/mL vial, 25 vials recalledLorazepam	Hikma Pharmaceuticals USA	Potency & Assay	Nationwide
17 Aug 2022Drug	CLASS II	Lorazepam Injection, USP, 4mg/mL vial, 25 vial recalledLorazepam	Hikma Pharmaceuticals USA	Potency & Assay	Nationwide
17 Aug 2022Drug	CLASS II	Lorazepam Injection, USP, 2mg/mL vial, 25 vial recalledLorazepam	Hikma Pharmaceuticals USA	Potency & Assay	Nationwide
27 Dec 2017Drug	CLASS I	Lorazepam Oral Concentrate, USP, 2 mg/mL recalledLorazepam	Amneal Pharmaceuticals of New York	Other	Nationwide
29 Nov 2017Drug	CLASS II	Lorazepam Tablets, USP CIV, 5 mg recalled by Leading PharmaLorazepam	Leading Pharma	Other	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.